KHSRP and metabolic dysfunction-associated steatotic liver disease: Notably, we detected reduced expression of KHSRP, which has been reported as a splicing factor and shows altered expression levels in nonalcoholic fatty liver disease (NAFLD), hepatocellular carcinoma (HCC), and schistosome-induced hepatic fibrosis [27–29].